Interaction of botulinum toxin with the epithelial barrier

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Fujinaga, Yukako ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BOTULINUM TOXIN F; GANGLIOSIDE GD 1B; HEMAGGLUTININ; N ACETYLLACTOSAMINE SYNTHASE; PHOSPHATIDYLETHANOLAMINE; PROTEINASE; SYNAPTOTAGMIN I; SYNAPTOTAGMIN II; ZINC;

ABDOMINAL CRAMP; CARBOXY TERMINAL SEQUENCE; CELL DAMAGE; CELL SURFACE; CLOSTRIDIUM BOTULINUM TYPE A; CRYSTALLOGRAPHY; CYTOLOGY; DIARRHEA; DIGESTIVE SYSTEM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTESTINE EPITHELIUM; MOLECULAR BIOLOGY; MOUTH CAVITY; MUCOSA; NAUSEA; NEUROTRANSMITTER RELEASE; NONHUMAN; PERMEABILITY BARRIER; REVIEW; TRANSMISSION ELECTRON MICROSCOPY; VOMITING; ANIMAL; BOTULISM; CHEMISTRY; EPITHELIUM; GASTROINTESTINAL TRACT; METABOLISM;

ANIMALS; BOTULINUM TOXINS; BOTULISM; EPITHELIUM; GASTROINTESTINAL TRACT; HUMANS;

EID: 77954575803     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/974943     Document Type: Review

References (77)

1. S. S. Arnon, R. Schechter, T. V. Inglesby, et al., "Botulinum toxin as a biological weapon: medical and public health management," Journal of the American Medical Association, vol. 285, no. 8, pp. 1059-1070, 2001. (Pubitemid 32176420)
2. G. Schiavo, M. Matteoli, and C. Montecucco, "Neurotoxins affecting neuroexocytosis," Physiological Reviews, vol. 80, no. 2, pp. 717-766, 2000. (Pubitemid 30164948)
3. G. Sakaguchi, "Clostridium botulinum toxins," Pharmacology & Therapeutics, vol. 19, no. 2, pp. 165-194, 1982. (Pubitemid 13112836)
4. N. P. Minton, "Molecular genetics of clostridial neurotoxins," Current Topics in Microbiology and Immunology, vol. 195, pp. 161-194, 1995.
5. M. D. Collins and A. K. East, "Phylogeny and taxonomy of the food-borne pathogen Clostridium botulinum and its neurotoxins," Journal of Applied Microbiology, vol. 84, no. 1, pp. 5-17, 1998. (Pubitemid 28123864)
6. K. Oguma, K. Inoue, Y. Fujinaga, et al., "Structure and function of Clostridium botulinum progenitor toxin," Journal of Toxicology-Toxin Reviews, vol. 18, no. 1, pp. 17-34, 1999. (Pubitemid 29129395)
7. B. Poulain, M. R. Popoff, and J. Molgo, "How do the Botulinum Neurotoxins block neurotransmitter release: from botulinum to the molecular mechanism of action," The Botulinum Journal, vol. 1, no. 1, pp. 14-87, 2008.
8. P. F. Bonventre, "Absorption of botulinal toxin from the gastrointestinal tract," Reviews of Infectious Diseases, vol. 1, no. 4, pp. 663-667, 1979.
9. S. Sugii, I. Ohishi, and G. Sakaguchi, "Intestinal absorption of botulinum toxins of different molecular sizes in rats," Infection and Immunity, vol. 17, no. 3, pp. 491-496, 1977. (Pubitemid 8184173)
10. T. Binz and A. Rummel, "Cell entry strategy of clostridial neurotoxins," Journal of Neurochemistry, vol. 109, no. 6, pp. 1584-1595, 2009.
11. T. J. Smith, J. Lou, I. N. Geren, et al., "Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization," Infection and Immunity, vol. 73, no. 9, pp. 5450-5457, 2005. (Pubitemid 41192979)
12. J. W. Arndt, M. J. Jacobson, E. E. Abola, et al., "A structural perspective of the sequence variability within Botulinum Neurotoxin subtypes A1-A4," Journal of Molecular Biology, vol. 362, no. 4, pp. 733-742, 2006. (Pubitemid 44404084)
13. K. K. Hill, T. J. Smith, C. H. Helma, et al., "Genetic diversity among botulinum neurotoxin-producing clostridial strains," Journal of Bacteriology, vol. 189, no. 3, pp. 818-832, 2007. (Pubitemid 46183856)
14. T. J. Smith, K. K. Hill, B. T. Foley, et al., "Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3,/Ba4 and/B1 clusters are located within plasmids," PLoS One, vol. 2, no. 12, p. e1271, 2007.
15. A. T. Carter, C. J. Paul, D. R. Mason, et al., "Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum," BMC Genomics, vol. 10, article 115, 2009.
16. K. Inoue, Y. Fujinaga, T. Watanabe, et al., "Molecular composition of Clostridium botulinum type A progenitor toxins," Infection and Immunity, vol. 64, no. 5, pp. 1589-1594, 1996. (Pubitemid 26129820)
17. M. Dong, F. Yeh, W. H. Tepp, et al., "SV2 is the protein receptor for botulinum neurotoxin A," Science, vol. 312, no. 5773, pp. 592-596, 2006.
18. S. Mahrhold, A. Rummel, H. Bigalke, B. Davletov, and T. Binz, "The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves," FEBS Letters, vol. 580, no. 8, pp. 2011-2014, 2006.
19. M. Dong, H. Liu, W. H. Tepp, E. A. Johnson, R. Janz, and E. R. Chapman, "Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons," Molecular Biology of the Cell, vol. 19, no. 12, pp. 5226-5237, 2008.
20. A. Rummel, K. Hafner, S. Mahrhold, et al., "Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor," Journal of Neurochemistry, vol. 110, no. 6, pp. 1942-1954, 2009.
21. T.-I. Nishiki, Y. Kamata, Y. Nemoto, et al., "Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes," Journal of Biological Chemistry, vol. 269, no. 14, pp. 10498-10503, 1994. (Pubitemid 24198248)
22. T.-I. Nishiki, Y. Tokuyama, Y. Kamata, et al., "The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a," FEBS Letters, vol. 378, no. 3, pp. 253-257, 1996.
23. T.-I. Nishiki, Y. Tokuyama, Y. Kamata, et al., "Binding of botulinum type B neurotoxin to Chinese hamster ovary cells transfected with rat synaptotagmin II cDNA," Neuroscience Letters, vol. 208, no. 2, pp. 105-108, 1996. (Pubitemid 26128119)
24. M. Dong, D. A. Richards, M. C. Goodnough, W. H. Tepp, E. A. Johnson, and E. R. Chapman, "Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells," Journal of Cell Biology, vol. 162, no. 7, pp. 1293-1303, 2003. (Pubitemid 37210885)
25. A. Rummel, T. Karnath, T. Henke, H. Bigalke, and T. Binz, "Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G," Journal of Biological Chemistry, vol. 279, no. 29, pp. 30865-30870, 2004. (Pubitemid 38938022)
26. M. Dong, W. H. Tepp, H. Liu, E. A. Johnson, and E. R. Chapman, "Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons," Journal of Cell Biology, vol. 179, no. 7, pp. 1511-1522, 2007.
27. A. Rummel, T. Eichner, T. Weil, et al., "Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 1, pp. 359-364, 2007. (Pubitemid 46068036)
28. K. Tsukamoto, T. Kohda, M. Mukamoto, et al., "Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid: novel insights into the receptor for clostridial neurotoxins," Journal of Biological Chemistry, vol. 280, no. 42, pp. 35164-35171, 2005. (Pubitemid 41532703)
29. L. K. Koriazova and M. Montal, "Translocation of botulinum neurotoxin light chain protease through the heavy chain channel," Nature Structural Biology, vol. 10, no. 1, pp. 13-18, 2003. (Pubitemid 36034171)
30. A. Fischer and M. Montal, "Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 25, pp. 10447-10452, 2007. (Pubitemid 47185685)
31. A. Fischer, D. J. Mushrush, D. B. Lacy, et al., "Botulinum neurotoxin devoid of receptor binding domain translocates active protease," PLoS Pathogens, vol. 4, no. 12, Article ID e1000245, 2008.
32. D. B. Lacy, W. Tepp, A. C. Cohen, B. R. DasGupta, and R. C. Stevens, "Crystal structure of botulinum neurotoxin type A and implications for toxicity," Nature Structural Biology, vol. 5, no. 10, pp. 898-902, 1998. (Pubitemid 28467413)
33. R. Agarwal, S. Eswaramoorthy, D. Kumaran, T. Binz, and S. Swaminathan, "Structural analysis of botulinum neurotoxin type E catalytic domain and its mutant Glu212 → Gln reveals the pivotal role of the Glu212 carboxylate in the catalytic pathway," Biochemistry, vol. 43, no. 21, pp. 6637-6644, 2004. (Pubitemid 38697563)
34. R. Agarwal, T. Binz, and S. Swaminathan, "Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design," Biochemistry, vol. 44, no. 35, pp. 11758-11765, 2005. (Pubitemid 41262710)
35. J. W. Arndt, W. Yu, F. Bi, et al., "Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition," Biochemistry, vol. 44, no. 28, pp. 9574-9580, 2005. (Pubitemid 40994351)
36. J. W. Arndt, Q. Chai, T. Christian, and R. C. Stevens, "Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity," Biochemistry, vol. 45, no. 10, pp. 3255-3262, 2006. (Pubitemid 43376344)
37. D. Kumaran, S. Eswaramoorthy, W. Furey, J. Navaza, M. Sax, and S. Swaminathan, "Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation," Journal of Molecular Biology, vol. 386, no. 1, pp. 233-245, 2009.
38. M. A. Breidenbach and A. T. Brunger, "Substrate recognition strategy for butulinum neurotoxin serotype A," Nature, vol. 432, no. 7019, pp. 925-929, 2004. (Pubitemid 40037157)
39. B. Segelke, M. Knapp, S. Kadkhodayan, R. Balhorn, and B. Rupp, "Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: evidence for noncanonical zinc protease activity," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 18, pp. 6888-6893, 2004. (Pubitemid 38596413)
40. D. Kumaran, R. Rawat, S. A. Ahmed, et al., "Substrate binding mode and its implication on drug design for botulinum neurotoxin A," PLoS Pathogens, vol. 4, no. 9, Article ID e1000165, 2008.
41. S. Swaminathan and S. Eswaramoorthy, "Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B," Nature Structural Biology, vol. 7, no. 8, pp. 693-699, 2000. (Pubitemid 30636683)
42. Q. Chai, J. W. Arndt, M. Dong, et al., "Structural basis of cell surface receptor recognition by botulinum neurotoxin B," Nature, vol. 444, no. 7122, pp. 1096-1100, 2006. (Pubitemid 46018532)
43. R. Jin, A. Rummel, T. Binz, and A. T. Brunger, "Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity," Nature, vol. 444, no. 7122, pp. 1092-1095, 2006. (Pubitemid 46018531)
44. P. Stenmark, J. Dupuy, A. Imamura, et al., "Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b-insight into the toxin-neuron interaction," PLoS Pathogens, vol. 4, no. 8, Article ID e1000129, 2008.
45. K. Miyata, T. Yoneyama, T. Suzuki, et al., "Expression and stability of the nontoxic component of the botulinum toxin complex," Biochemical and Biophysical Research Communications, vol. 384, no. 1, pp. 126-130, 2009.
46. K. Hasegawa, T. Watanabe, T. Suzuki, et al., "A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms," The Journal of Biological Chemistry, vol. 282, no. 34, pp. 24777-24783, 2007. (Pubitemid 47347510)
47. S. Mutoh, H. Kouguchi, Y. Sagane, et al., "Complete subunit structure of the Clostridium botulinum type D toxin complex via intermediate assembly with nontoxic components," Biochemistry, vol. 42, no. 37, pp. 10991-10997, 2003. (Pubitemid 37174390)
48. T. Suzuki, T. Watanabe, S. Mutoh, et al., "Characterization of the interaction between subunits of the botulinum toxin complex produced by serotype D through tryptic susceptibility of the isolated components and complex forms," Microbiology, vol. 151, part 5, pp. 1475-1483, 2005. (Pubitemid 40711794)
49. K. Inoue, M. Sobhany, T. R. Transue, et al., "Structural analysis by X-ray crystallography and calorimetry of a haemagglutinin component (HA1) of the progenitor toxin from Clostridium botulinum," Microbiology, vol. 149, part 12, pp. 3361-3370, 2003. (Pubitemid 38016665)
50. T. Nakamura, T. Tonozuka, A. Ide, T. Yuzawa, K. Oguma, and A. Nishikawa, "Sugar-binding sites of the HA1 subcomponent of Clostridium botulinum type C progenitor toxin," Journal of Molecular Biology, vol. 376, no. 3, pp. 854-867, 2008.
51. J. W. Arndt, J. Gu, L. Jaroszewski, et al., "The structure of the neurotoxin-associated protein HA33/A from Clostridium botulinum suggests a reoccurring β-trefoil fold in the progenitor toxin complex," Journal of Molecular Biology, vol. 346, no. 4, pp. 1083-1093, 2005. (Pubitemid 40215532)
52. T. Nakamura, M. Kotani, T. Tonozuka, A. Ide, K. Oguma, and A. Nishikawa, "Crystal structure of the HA3 subcomponent of Clostridium botulinum type C progenitor toxin," Journal of Molecular Biology, vol. 385, no. 4, pp. 1193-1206, 2009.
53. C. Lamanna, R. A. Hillowalla, and C. C. Alling, "Buccal exposure to botulinal toxin," Journal of Infectious Diseases, vol. 117, no. 4, pp. 327-331, 1967.
54. A. B. Maksymowych, M. Reinhard, C. J. Malizio, M. C. Good-nough, E. A. Johnson, and L. L. Simpson, "Pure botulinum neurotoxin is absorbed from the stomach and small intestine and produces peripheral neuromuscular blockade," Infection and Immunity, vol. 67, no. 9, pp. 4708-4712, 1999. (Pubitemid 29400453)
55. J.-B. Park and L. L. Simpson, "Inhalational poisoning by botulinum toxin and inhalation vaccination with its heavy-chain component," Infection and Immunity, vol. 71, no. 3, pp. 1147-1154, 2003. (Pubitemid 36254295)
56. S. Sugii, I. Ohishi, and G. Sakaguchi, "Correlation between oral toxicity and in vitro stability of Clostridium botulinum type A and B toxins of different molecular sizes," Infection and Immunity, vol. 16, no. 3, pp. 910-914, 1977. (Pubitemid 8112763)
57. S. Cai, H. K. Sarkar, and B. R. Singh, "Enhancement of the endopeptidase activity of botulinum neurotoxin by its associated proteins and dithiothreitol," Biochemistry, vol. 38, no. 21, pp. 6903-6910, 1999.
58. S. K. Sharma and B. R. Singh, "Enhancement of the endopep-tidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins," Biochemistry, vol. 43, no. 16, pp. 4791-4798, 2004. (Pubitemid 38509100)
59. Y. Zhou, S. Foss, P. Lindo, H. Sarkar, and B. R. Singh, "Hemagglutinin-33 of type A botulinum neurotoxin complex binds with synaptotagmin II," FEBS Journal, vol. 272, no. 11, pp. 2717-2726, 2005. (Pubitemid 40825419)
60. R. V. Kukreja and B. R. Singh, "Comparative role of neurotoxin-associated proteins in the structural stability and endopeptidase activity of botulinum neurotoxin complex types A and E," Biochemistry, vol. 46, no. 49, pp. 14316-14324, 2007. (Pubitemid 350250324)
61. A. B. Maksymowych and L. L. Simpson, "Binding and transcytosis of botulinum neurotoxin by polarized human colon carcinoma cells," Journal of Biological Chemistry, vol. 273, no. 34, pp. 21950-21957, 1998. (Pubitemid 28405374)
62. A. B. Maksymowych and L. L. Simpson, "Structural features of the botulinum neurotoxin molecule that govern binding and transcytosis across polarized human intestinal epithelial cells," Journal of Pharmacology and Experimental Therapeutics, vol. 310, no. 2, pp. 633-641, 2004. (Pubitemid 38988908)
63. C. R. Ahsan, G. Hajnoczky, A. B. Maksymowych, and L. L. Simpson, "Visualization of binding and transcytosis of botulinum toxin by human intestinal epithelial cells," Journal of Pharmacology and Experimental Therapeutics, vol. 315, no. 3, pp. 1028-1035, 2005. (Pubitemid 41635388)
64. A. Couesnon, Y. Pereira, and M. R. Popoff, "Receptor-mediated transcytosis of botulinum neurotoxin A through intestinal cell monolayers," Cellular Microbiology, vol. 10, no. 2, pp. 375-387, 2008.
65. T. Matsumura, Y. Jin, Y. Kabumoto, et al., "The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption," Cellular Microbiology, vol. 10, no. 2, pp. 355-364, 2008.
66. A. Couesnon, T. Shimizu, and M. R. Popoff, "Differential entry of botulinum neurotoxin A into neuronal and intestinal cells," Cellular Microbiology, vol. 11, no. 2, pp. 289-308, 2009.
67. Y. Fujinaga, K. Inoue, S. Watanabe, et al., "The haemagglutinin of Clostridium botulinum type C progenitor toxin plays an essential role in binding of toxin to the epithelial cells of guinea pig small intestine, leading to the efficient absorption of the toxin," Microbiology, vol. 143, part 12, pp. 3841-3847, 1997. (Pubitemid 28004616)
68. A. Nishikawa, N. Uotsu, H. Arimitsu, et al., "The receptor and transporter for internalization of Clostridium botulinum type C progenitor toxin into HT-29 cells," Biochemical and Biophysical Research Communications, vol. 319, no. 2, pp. 327-333, 2004. (Pubitemid 38725950)
69. N. Uotsu, A. Nishikawa, T. Watanabe, et al., "Cell internal-ization and traffic pathway of Clostridium botulinum type C neurotoxin in HT-29 cells," Biochimica et Biophysica Acta, vol. 1763, no. 1, pp. 120-128, 2006. (Pubitemid 43208739)
70. K. Niwa, K. Koyama, S.-I. Inoue, et al., "Role of nontoxic components of serotype D botulinum toxin complex in permeation through a Caco-2 cell monolayer, a model for intestinal epithelium," FEMS Immunology and Medical Microbiology, vol. 49, no. 3, pp. 346-352, 2007. (Pubitemid 46435011)
71. Y. Fujinaga, K. Inoue, T. Nomura, et al., "Identification and characterization of functional subunits of Clostridium botulinum type A progenitor toxin involved in binding to intestinal microvilli and erythrocytes," FEBS Letters, vol. 467, no. 2-3, pp. 179-183, 2000. (Pubitemid 30081730)
72. +-PTX) binds to oligosaccharides containing Gal beta1-4GlcNAc through one subcomponent of haemagglutinin (HA1)," Microbiology, vol. 147, part 4, pp. 811-819, 2001. (Pubitemid 32401321)
73. S. Kojima, H. Eguchi, T. Ookawara, et al., "Clostridium botulinum type A progenitor toxin binds to Intestine-407 cells via N-acetyllactosamine moiety," Biochemical and Biophysical Research Communications, vol. 331, no. 2, pp. 571-576, 2005. (Pubitemid 40602676)
74. Y. Fujinaga, K. Inoue, S. Watarai, et al., "Molecular characterization of binding subcomponents of Clostridium botulinum type C progenitor toxin for intestinal epithelial cells and erythrocytes," Microbiology, vol. 150, pp. 1529-1538, 2004. (Pubitemid 38744754)
75. H. Arimitsu, Y. Sakaguchi, J.-C. Lee, et al., "Molecular properties of each subcomponent in Clostridium botulinum type B haemagglutinin complex," Microbial Pathogenesis, vol. 45, no. 2, pp. 142-149, 2008.
76. Y. Sagane, H. Kouguchi, T. Watanabe, et al., "Role of C-terminal region of HA-33 component of botulinum toxin in hemagglutination," Biochemical and Biophysical Research Communications, vol. 288, no. 3, pp. 650-657, 2001. (Pubitemid 33030079)
77. Y. Jin, Y. Takegahara, Y. Sugawara, et al., "Disruption of the epithelial barrier by botulinum haemagglutinin (HA) proteins-differences in cell tropism and the mechanism of action between HA proteins of types A or B, and HA proteins of type C," Microbiology, vol. 155, part 1, pp. 35-45, 2009.